Pages
Products
Human PTEN adenoviral particles

Human PTEN adenoviral particles

Cat.No. :  AD00240Z

Titer: ≥1x10^10 IFU/mL / ≥1x10^11 IFU/mL / ≥1x10^11 VP/mL / ≥1x10^12 VP/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Adenovirus Particle Information

Quality Control

Gene Informationn

Cat. No. AD00240Z
Target Gene PTEN
Species Human
Product Type Adenoviral particle
Insert PTEN
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 250 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Gene Name
Gene Symbol
Synonyms
Gene Description
Gene ID
UniProt ID
mRNA Refseq
Protein Refseq
Chromosome Location
Function
Pathway
MIM
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

The phosphatase and tensin homolog (PTEN) gene is a key tumor suppressor that plays a central role in regulating cell proliferation, survival, and metabolism. PTEN is located on chromosome 10q23 and encodes a lipid phosphatase that primarily antagonizes the PI3K/AKT/mTOR signaling pathway, a key driver of tumorigenesis. PTEN inhibits AKT activation by dephosphorylating phosphatidylinositol (3,4,5)-triphosphate (PIP3), thereby inhibiting cell growth and promoting apoptosis. Mutations or deletions of PTEN are commonly found in a variety of cancers, including glioblastoma, prostate cancer, and breast cancer, leading to uncontrolled cell proliferation and tumor progression. In addition to its role in cancer, PTEN has been implicated in metabolic disorders, neurodegenerative diseases, and autoimmune diseases. Human PTEN Adenoviral Particles are genetically engineered recombinant adenoviruses designed to efficiently deliver the PTEN gene to target cells. Adenoviral vectors are favored for their ability to infect both dividing and non-dividing cells, thereby ensuring stable expression of the transgene. These particles are replication-defective, which enhances safety for both research and therapeutic applications. The viral genome has been modified to carry human PTEN under the control of a strong promoter, allowing for sustained expression of PTEN during transduction. Human PTEN adenoviral particles are widely used in functional studies aimed at restoring PTEN activity in PTEN-deficient cancer cells, helping researchers to investigate its tumor suppressor mechanisms. In addition, they are valuable tools for exploring the role of PTEN in signaling pathways, cellular senescence, and metabolic regulation.

The phosphatase and tensin homolog deleted from chromosome 10 (PTEN) pathway has been extensively examined in many cancer studies. Only a few reports have suggested that PTEN may affect pain; however, evidence for the role of PTEN in pain regulation is still lacking. Here, researchers found that chronic constriction injury (CCI) surgery in rats induced downregulation of spinal PTEN and upregulation of phosphorylated PTEN (phospho-PTEN) and phosphorylated mammalian target of rapamycin (phospho-mTOR). After examining such changes in endogenous PTEN in neuropathic rats, researchers explored the effects of modulating the spinal PTEN pathway on nociceptive behavior. Normal rats exhibited mechanical allodynia after intrathecal (i.t.) injection of adenovirus-mediated PTEN antisense oligonucleotides (Ad-antisense PTEN). Furthermore, upregulation of spinal PTEN by intrathecal adenovirus-mediated PTEN (Ad-PTEN) significantly prevented the development of CCI-induced nociceptive sensitization, thermal hyperalgesia, mechanical allodynia, cold allodynia, and weight-bearing deficits in neuropathic rats. Furthermore, upregulation of spinal PTEN by intrathecal Ad-PTEN significantly attenuated CCI-induced microglial and astrocyte activation, upregulation of tumor necrosis factor-α (TNF-α) and phosphorylated mTOR, and downregulation of PTEN 14 days after injury in neuropathic rats. These findings suggest that PTEN plays a critical beneficial role in rodent models of neuropathic pain.

Here, to verify that Ad-PTEN is able to upregulate the production of PTEN in the spinal cord, the researchers prepared the following three groups of rats: (1) naïve rats plus i.t. vector, (2) naive rats plus i.t. Ad-GFP, and (3) naïve rats plus i.t. Ad-PTEN. The researchers observed no significant difference in spinal PTEN expression between naive rats plus i.t. vector (Figure 1A) and rats examined 14 days after i.t. injection of Ad-GFP (Figure 1B), while PTEN immunoreactivity increased after 14 days of i.t. Ad-PTEN (Figure 1C). Quantification of immunoreactivity results (Figure 1D) further confirmed the upregulation of PTEN in the naive rats plus i.t. Ad-PTEN group 14 days after i.t. injection. Confocal double immunostaining images of the lumbar dorsal gray matter further confirmed that in the naïve rats administered i.t. Ad-PTEN, most PTEN signals colocalized with GFAP-positive cells (astrocytes; Figure 1F ) more often than with NeuN-positive cells (neuronal cells; Figure 1E ) or OX-42-positive cells (microglia; Figure 1G ).

The effects of i.t. injection of Ad-PTEN on PTEN in the dorsal lumbar spinal cord.Figure 1. The effects of i.t. injection of Ad-PTEN on PTEN in the dorsal lumbar spinal cord. (Huang S Y, et al., 2015)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Accelerated our research progress

Time is crucial for the delivery of our grant projects. Using these pre-made PTEN adenoviral particles saved us weeks compared to producing them ourselves. Rapid delivery and ready-to-use quality were key.

French

03/01/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER